Literature DB >> 20638598

Two-decade trends in primary Helicobacter pylori resistance to antibiotics in Bulgaria.

Lyudmila Boyanova1, Rossen Nikolov, Galina Gergova, Ivailo Evstatiev, Elena Lazarova, Victor Kamburov, Emilia Panteleeva, Zoya Spassova, Ivan Mitov.   

Abstract

Evaluating long-term trends in antibiotic resistance can predict earlier the short-term changes in resistance patterns. The aim of the present study was to compare primary resistance rates in 501 Helicobacter pylori strains in 2007 to 2009 to those in 1990 to 1995 (179 strains) and the antibiotic MICs to detect the 20-year resistance evolution. In 2007 to 2009, strains from children exhibited lower resistance rates to metronidazole (16.4%) and ciprofloxacin (2.7%) than those from adults (27.3% and 10.3%, respectively). In 2008 to 2009, more children (29.3%) harbored clarithromycin-resistant strains compared to the adults (17.4%). Overall clarithromycin resistance rate (19.4%) in 2007 to 2009 was much higher than that in 1990 to 1995 (6.2%). MIC(90) of erythromycin in 1990 to 1995 was 142.2-fold lower than that of clarithromycin in 2007 to 2009. Clarithromycin MIC(90) increased >42-fold since 2001 to 2004. Quinolone resistance rate increased 7.7-fold, being 9.2% in 2007 to 2009 versus 1.2% in 1990 to 1995, with a 5-fold increase in MIC(90). Conversely, the amoxicillin resistance decreased from 3.2% in 1996 to 1999 to 0.4% in 2007 to 2009. The MIC(90)'s of tetracycline remained stable but MIC(50)'s of both metronidazole and tetracycline before 1996 decreased about 4-fold to 2007 to 2009. In conclusion, associations between the resistance evolution and patients' age groups as well as the national outpatient antibiotic use have been found. H. pylori resistance to antibiotics showed many long-term changes, with a more rapid evolution for clarithromycin than for the other antibiotics. Metronidazole and tetracycline did not show a resistance evolution but exhibited a decrease in MIC(50) since 1990. The significant increase in ciprofloxacin resistance was found only by extending the study period to 20 years. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638598     DOI: 10.1016/j.diagmicrobio.2010.03.010

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  8 in total

1.  Antibiotic resistance of Helicobacter pylori in pediatric patients -- 10 years' experience.

Authors:  Iva Hojsak; Tea Kos; Jelena Dumančić; Zrinjka Mišak; Oleg Jadrešin; Alemka Jaklin Kekez; Amarela Lukić Grlić; Sanja Kolaček
Journal:  Eur J Pediatr       Date:  2012-03-20       Impact factor: 3.183

2.  Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium.

Authors:  V Y Miendje Deyi; V Y Miendje Deyi; P Bontems; J Vanderpas; E De Koster; R Ntounda; C Van den Borre; S Cadranel; A Burette
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

3.  Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned?

Authors:  Doron Boltin; Haim Ben-Zvi; Tsachi Tsadok Perets; Zvi Kamenetsky; Zmira Samra; Ram Dickman; Yaron Niv
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

Review 4.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

Review 5.  Review article: the global emergence of Helicobacter pylori antibiotic resistance.

Authors:  I Thung; H Aramin; V Vavinskaya; S Gupta; J Y Park; S E Crowe; M A Valasek
Journal:  Aliment Pharmacol Ther       Date:  2015-12-23       Impact factor: 8.171

6.  Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori.

Authors:  Konrad Egli; Karoline Wagner; Peter M Keller; Lorenz Risch; Martin Risch; Thomas Bodmer
Journal:  Front Cell Infect Microbiol       Date:  2020-12-17       Impact factor: 5.293

7.  CagA status & genetic characterization of metronidazole resistant strains of H. pylori from: A region at high risk of gastric cancer.

Authors:  Jin-Yong Yue; Jing Yue; Ming-Yi Wang; Wen-Chong Song; Xiao-Zhong Gao
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

8.  Systematic identification of immunodominant CD4+ T cell responses to HpaA in Helicobacter pylori infected individuals.

Authors:  Jian Hu; Li Chen; Wuchen Yang; Bin Li; Heqiang Sun; Shanshan Wei; Yafei He; Zhuo Zhao; Shiming Yang; Quanming Zou; Weisan Chen; Hong Guo; Chao Wu
Journal:  Oncotarget       Date:  2016-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.